Brexpiprazole: a new dopamine D2 receptor partial agonist for the treatment of schizophrenia and major depressive disorder
Year: 2015
Type: article
Source: Drugs of today
Author: Citrome, L.
Institution: New York Medical College
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2199930390
